Sale!

FANCD2 Gene Fanconi anemia type D2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FANCD2 Gene Fanconi Anemia type D2 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the FANCD2 gene, which is crucial for diagnosing Fanconi Anemia (FA) type D2. Fanconi Anemia is a rare genetic disorder that affects the bone marrow, leading to decreased production of all types of blood cells. This condition can also predispose individuals to cancer and cause various congenital abnormalities.

The FANCD2 gene plays a significant role in the FA pathway, a crucial DNA repair mechanism. Mutations in this gene can disrupt the pathway, leading to the characteristic symptoms and complications of FA. Early detection through genetic testing is vital for managing the disease effectively, as it allows for timely intervention and personalized treatment plans.

This specific genetic test is available at DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The test cost is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the FANCD2 gene. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, which are essential for confirming the diagnosis of Fanconi Anemia type D2 and facilitating appropriate medical and genetic counseling.

Description

FANCD2 Gene Fanconi anemia type D2 Genetic Test

Test Name: FANCD2 Gene Fanconi anemia type D2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FANCD2 Gene Fanconi anemia type D2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Fanconi anemia type D2.

Test Details:

The FANCD2 gene is associated with Fanconi anemia type D2, which is a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular disorder or condition. In the case of Fanconi anemia type D2, NGS genetic testing can be used to identify variations or mutations in the FANCD2 gene that may be causing the disorder.

NGS genetic testing involves sequencing the DNA of an individual to identify any variations or mutations in specific genes. This can help in the diagnosis of genetic disorders, as well as in providing information about the risk of developing certain conditions or the likelihood of passing on genetic conditions to future generations.

In the case of Fanconi anemia type D2, NGS genetic testing can help confirm a diagnosis, provide information about the severity of the condition, and guide treatment options. It can also be used for carrier testing, which can help determine the risk of passing on the condition to offspring.

It is important to note that NGS genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.

Test Name	FANCD2 Gene Fanconi anemia type D2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FANCD2 Gene Fanconi anemia type D2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Fanconi anemia type D2
Test Details	The FANCD2 gene is associated with Fanconi anemia type D2, which is a rare genetic disorder characterized by bone marrow failure, developmental abnormalities, and an increased risk of cancer. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular disorder or condition. In the case of Fanconi anemia type D2, NGS genetic testing can be used to identify variations or mutations in the FANCD2 gene that may be causing the disorder. NGS genetic testing involves sequencing the DNA of an individual to identify any variations or mutations in specific genes. This can help in the diagnosis of genetic disorders, as well as in providing information about the risk of developing certain conditions or the likelihood of passing on genetic conditions to future generations. In the case of Fanconi anemia type D2, NGS genetic testing can help confirm a diagnosis, provide information about the severity of the condition, and guide treatment options. It can also be used for carrier testing, which can help determine the risk of passing on the condition to offspring. It is important to note that NGS genetic testing should be conducted under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.